← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Baskies Arnold M
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001683567
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 2
- Purchases · 24M
- 4
- Average purchase
- $18.8K
- Median purchase
- $15.5K
- Gross purchase value
- $75.2K
Companies: Anixa Biosciences Inc
4 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-09-28 | Anixa Biosciences Inc | ANIX | Director | $13.8K | Open filing |
| 2026-01-29 | Anixa Biosciences Inc | ANIX | Director | $30.4K | Open filing |
| 2025-07-21 | Anixa Biosciences Inc | ANIX | Director | $16.9K | Open filing |
| 2025-01-29 | Anixa Biosciences Inc | ANIX | Director | $14.1K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small Sample | 100.0% (4/4) | 25.0% (1/4) | -2.9% | -2.5% | -8.9% |
| 20D | 3Small Sample | 100.0% (3/3) | 33.3% (1/3) | -2.7% | -4.3% | -15.4% |
| 60D | 3Small Sample | 100.0% (3/3) | 66.7% (2/3) | +0.2% | +4.4% | -7.5% |
| 120D | 3Small Sample | 100.0% (3/3) | 66.7% (2/3) | +6.7% | +2.7% | -12.5% |
Research patterns
- First purchase in 12M
- 0/3
- Large purchase ≥ $100k
- 0/4
- Cluster buying · 15D
- 3/4
- Buying the dip
- 3/4
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.